Jin-Xiu Chen

Jin-Xiu Chen

Auto-generated profile, based on publicly available information

Jin-Xiu Chen

School of Nursing, Fujian University of Traditional Chinese Medicine, Fuzhou, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2013 in Rehabilitation Nursing Journal
Verified
Journal Article
Closed access
PDF file
XLXianliang Liu
Xianliang Liu
Benjamin TanBenjamin Tan
Benjamin Tan
TWTao Wang
Tao Wang
QZQi Zhang
Qi Zhang
MZMin Zhang
Min Zhang
JCJin-Xiu Chen
Jin-Xiu Chen

12 November 2012 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LMLijuan Mei
Lijuan Mei
QCQingyue Chen
Qingyue Chen
LGLi Ge
Li Ge
GZGuohua Zheng
Guohua Zheng
JCJinxiu Chen
Jinxiu Chen
Background. Baduanjin exercise is considered to be beneficial to modulate the blood lipid metabolism. The purpose of the systematic review was to assess the potential efficacy and safety of Baduanjin exercise.Methods. MEDLINE, EMBASE, CBM, CNKI, VIP, Chinese Important Conference Papers Database, and Chinese Dissertation Database were searched for all prospective-controlled trials of Baduanjin exercise from their inception to December 31, 2011.Results. A total of 14 studies were included. Comparing with no treatment, Baduanjin exercise significantly reduced the levels of TC, TG, LDL-C in plasma, and elevated plasma HDL-C level for healthy participants, and the pooled MD (95% confidence interval, CI) was −0.58 mmol/L (−0.86, −0.30 mmol/L), −0.22 mmol/L (−0.31, −0.13 mmol/L), −0.35 mmol/L (−0.54, −0.17 mmol/L), 0.13 mmol/L (0.06, 0.21 mmol/L), respectively. Baduanjin exercise also obviously decreased the levels of TG, LDL-C in plasma comparing with no treatment for patients, and the pooled MD (95% CI) was −0.30 mmol/L (−0.40, −0.19 mmol/L), −0.38 mmol/L (−0.63, −0.13 mmol/L), but there was not obvious to decrease plasma TC level or elevate plasma HDL-C level in patients with the pooled MD (95%CI), −0.39 mmol/L (−1.09, 0.31 mmol/L) and 0.22 mmol/L (−0.11, 0.55 mmol/L), respectively. In addition, the obvious advantage was not observed to modulate the blood lipid metabolism in comparing Baduanjin exercise with other exercises, regardless for health participants or patients.Conclusion. Studies indicated that Baduanjin exercise could significantly decrease the levels of TC, TG, LDL-C levels in plasma and elevate plasma HDL-C level for the healthy people. It also was helpful that Baduanjin exercise modulated the blood lipid metabolism for patients. Moreover, the Baduanjin exercise did not have an obvious advantage on modulating the lipid metabolism comparing with other exercises. But the evidence was uncertain because of the small sample size and low-methodological quality.

1 June 2018 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
LYLiu Yang
Liu Yang
Benjamin TanBenjamin Tan
Benjamin Tan
HMHaili Ma
Haili Ma
HZHongjia Zhao
Hongjia Zhao
JLJinghui Lai
Jinghui Lai
LSLorna Suen
Lorna Suen

3 November 2022 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
HZHong-Juan Zhou
Hong-Juan Zhou
TWTao Wang
Tao Wang
YXYong-Zhi Xu
Yong-Zhi Xu
YCYan-Nan Chen
Yan-Nan Chen
LDLi-Jing Deng
Li-Jing Deng
Benjamin TanBenjamin Tan
Benjamin Tan
Objective: This overview of systematic reviews aims to critically appraise and consolidate evidence from current systematic reviews (SRs)/meta-analyses on the effects of exercise interventions on cancer-related fatigue (CRF) in breast cancer patients. Methods: SRs/meta-analyses that explored the effects of exercise interventions on CRF in breast cancer patients compared with the routine methods of treatment and care were retrieved from nine databases. The methodological quality of the included SRs was appraised using A MeaSurement Tool to Assess systematic Reviews II (AMSTAR II). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to calculate the grading of outcomes in the included SRs. The exercise type, frequency, duration, and inclusion/absence of supervision were further evaluated with subgroup analyses. The Stata 16.0 software was utilized for data analysis. Results: Twenty-nine reviews were included. The overall methodological quality and level of evidence of the included reviews were unsatisfactory, with only three reviews rated as high methodological quality and no review identified as high-quality evidence. Moderate certainty evidence indicated that exercise could improve fatigue in breast cancer patients (SMD = − 0.40 [95%CI − 0.58, − 0.22]; P = 0.0001). Subgroup analysis based on the types of exercise showed that yoga (SMD = − 0.30 [95%CI − 0.56, − 0.05]; I2 = 28.7%) and aerobic exercise (SMD = − 0.29 [95%CI − 0.56, − 0.02]; I2 = 16%) had a significantly better effect on CRF in breast cancer patients; exercising for over 6 months (SMD = − 0.88 [95%CI − 1.59, − 0.17]; I2 = 42.7%; P = 0.0001), three times per week (SMD = − 0.77 [95%CI − 1.04, − 0.05]; I2 = 0%; P = 0.0001), and for 30 to 60 min per session (SMD = − 0.81 [95%CI − 1.15, − 0.47]; I2 = 42.3%; P = 0.0001) can contribute to a moderate improvement of CRF. Supervised exercise (SMD = − 0.48 [95%CI − 0.77, − 0.18]; I2 = 87%; P = 0.001) was shown to relieve CRF. Conclusion: Exercise played a favorable role in alleviating CRF in breast cancer. Yoga was recommended as a promising exercise modality for CRF management in the majority of the included studies. Exercising for at least three times per week with 30 to 60 min per session could be recommended as a suitable dosage for achieving improvement in CRF. Supervised exercise was found to be more effective in alleviating CRF than unsupervised exercise. More rigorously designed clinical studies are needed to specify the exact exercise type, duration, frequency, and intensity to have an optimal effect on CRF in breast cancer patients. Trial registration: ClinicalTrials.gov Identifier: CRD42020219866.

1 July 2012 in Geriatric Nursing
Verified
Journal Article
Closed access
Benjamin TanBenjamin Tan
Benjamin Tan
JCJin-Xiu Chen
Jin-Xiu Chen
XLXianliang Liu
Xianliang Liu
QZQi Zhang
Qi Zhang
MZMin Zhang
Min Zhang
RLRun Lin
Run Lin

1 January 2012 in World Chinese Journal of Digestology
Verified
Journal Article
Open access
MZMin Zhang
Min Zhang
JCJin-Xiu Chen
Jin-Xiu Chen
Benjamin TanBenjamin Tan
Benjamin Tan
XLXian-Liang Liu
Xian-Liang Liu
化疗后胃肠道黏膜炎的主要问题之一是其根本的发病机制尚未完全阐明, 研究者无法直接在人体上开展实验, 难以制定有效干预措施. 动物模型的应用在该领域的研究中起到极为关键的作用. 近年来, 研究者通过复制接近人体状态的动物模型, 在各类化疗药物的细胞机制和临床药理学研究方面取得了显著进展. 本文通过MeSH主题词结合自由词, 电子检索PubMed(1950-2011)、Science Direct(1823-2011)数据库, 对荷瘤大鼠化疗胃肠黏膜炎模型、胃肠黏膜炎非荷瘤模型、基因敲除和转基因动物模型进行综述, 全面分析各种化疗后胃肠道黏膜炎模型的造模方法及优缺点, 为今后研究化疗的胃肠黏膜毒性反应及其机制, 提供造模方面的选择和参考依据.